PALO
ALTO, Calif., July 29,
2024 /PRNewswire/ -- Varian, a Siemens
Healthineers company, announces receipt of 510(k) clearance from
the U.S. Food and Drug Administration (FDA) for its IntelliBlate
microwave ablation system, intended for ablation of soft tissue.
Designed to provide clinicians with greater predictability,
precision, and control during their procedures, IntelliBlate serves
as the cornerstone of a future-focused, integrated ecosystem for
microwave ablation.
IntelliBlate produces large, controlled spherical ablation zones
for predictable treatment delivery. With the option to utilize a
single or dual probes – each with linked or independent controls –
IntelliBlate delivers the versatility to meet the unique clinical
needs of each patient. Precision and control are amplified by the
Ximitry probe, which enables innovative features such as Laser Disk
Alignment and intuitive LED indicators.
The compact, versatile design and intuitive interface of
IntelliBlate delivers a portable and flexible system that reduces
barriers for this important treatment method. Modular elements
provide the flexibility for clinicians to expand their treatment
capabilities to meet changing clinical demands, all while keeping
control over operational efficiency throughout the ablation
procedure.
"IntelliBlate combines the features our customers say are most
important for an efficient, integrated solution to seek improved
levels of performance in microwave ablation," says Dr. David Hahn, Vice President and Chief Medical
Officer, Varian Interventional Solutions. "This innovative system
brings new versatility in treatment options, fueling
clinician-driven innovation to tackle a wide variety of cases.
Real-time monitoring and treatment information at the tissue level
aim to further empower care teams with the confidence to deliver
highly personalized care to patients."
The ability of IntelliBlate to act as a comprehensive microwave
ablation ecosystem is the result of deep collaboration between
Varian and clinical experts during the design and development
process. With future plans to connect intelligent therapeutic
technologies and image-guided innovations in a single platform,
IntelliBlate aims to provide clinicians with even greater
predictability of probe placement, treatment delivery, and
procedural confirmation.
"I'm excited to see that the development collaboration between
Varian and physicians resulted in the inclusion of much needed
features intended to improve the intervention for clinicians and
patients," says Dr. Venkatesh (Kavi)
Krishnasamy, Director of Interventional Oncology at
University of Alabama Birmingham. "From
their holistic design approach, it is clear they worked closely
with clinicians when developing IntelliBlate to meet our daily
needs. I look forward to the future integration of this Varian
treatment delivery system and Siemens Healthineers imaging
technology for continuous support from leading industry
partners."
Ablation techniques – including microwave ablation – represent
minimally invasive alternatives to surgery. Microwave ablation
achieves its results by delivering focused energy to localized
disease sites to destroy soft tissue, and is an increasingly
important part of a comprehensive portfolio of cancer care
options.
The IntelliBlate solution is the latest example of Varian's
commitment to becoming a leading innovator in interventional
solutions through continued investment in groundbreaking
technology. Together with Siemens Healthineers, we are committed to
continued development of an integrated approach to microwave
ablation that connects innovative therapy technologies and
image-guided solutions.
VARIAN, XIMITRY and INTELLIBLATE are trademarks of Varian
Medical Systems, Inc., pending or registered U.S. Pat. & Tm.
Off. Siemens Healthineers is trademark of Siemens Healthcare
GmbH registered U.S. Pat. & Tm. Off.
About Varian
At Varian, a Siemens Healthineers company, we envision a world
without fear of cancer. For more than 75 years, Varian has
developed, built, and delivered innovative technologies and
solutions that help care providers around the globe treat millions
of patients each year. Today, as a Siemens Healthineers company, we
support every step of the cancer care journey – from screening to
survivorship. From advanced imaging and radiation therapy to
comprehensive software and services, to interventional radiology,
we are harnessing the power of our perspective while also pursuing
clinical research to create a more efficient, and more personalized
care pathway. Because, for cancer patients everywhere, their fight
is our fight. For more information, visit
http://www.varian.com.
Press Contact
Kristin
Corey
Varian Corporate Communications
Kristin.Corey@varian.com
View original
content:https://www.prnewswire.com/news-releases/varian-announces-future-focused-integrated-microwave-ablation-ecosystem-with-intelliblate-302208027.html
SOURCE Varian